Open and collaborative research and development models: towards "commons" ?

Des modèles de recherche-développement ouverts et collaboratifs dans le domaine pharmaceutique: vers des « communs » ?

Anne Branciard ()
Additional contact information
Anne Branciard: SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale - IRD - Institut de Recherche pour le Développement - AMU - Aix Marseille Université - INSERM - Institut National de la Santé et de la Recherche Médicale

Post-Print from HAL

Keywords: malaria; ACT; research development; open source; open access; open innovation; global health; intellectual property rights; essential drugs; pharmaceutical industry; public-private partnerships; cost price; global public goods; commons; antipaludéens; médicaments essentiels; maladies infectieuses; recherche-développement; innovation ouverte; propriété intellectuelle; partenariat public-privé; gouvernance mondiale; politiques de santé; industrie pharmaceutique; prix coûtant; biens publics mondiaux; communs (search for similar items in EconPapers)
Date: 2012-09
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-02566715v1
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in 2012

Downloads: (external link)
https://shs.hal.science/halshs-02566715v1/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-02566715

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().